MiR-339-5p regulates the growth, colony formation and metastasis of colorectal cancer cells by targeting PRL-1

MicroRNAs (miRNAs) have been suggested to play a vital role in regulate tumor progression and invasion. However, the expression of miR-339-5p in colorectal cancer and its effects are not known. Here, we report that miR-339-5p is a tumor suppressor by regulating expression of PRL-1. In this study, we...

Full description

Saved in:
Bibliographic Details
Published in:PloS one Vol. 8; no. 5; p. e63142
Main Authors: Zhou, Chang, Liu, Guobing, Wang, Lijing, Lu, Yanxia, Yuan, Li, Zheng, Lin, Chen, Fang, Peng, Fanli, Li, Xuenong
Format: Journal Article
Language:English
Published: United States Public Library of Science 16-05-2013
Public Library of Science (PLoS)
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:MicroRNAs (miRNAs) have been suggested to play a vital role in regulate tumor progression and invasion. However, the expression of miR-339-5p in colorectal cancer and its effects are not known. Here, we report that miR-339-5p is a tumor suppressor by regulating expression of PRL-1. In this study, we showed that downregulated miR-339-5p levels in colorectal cancer tissues and highly invasive CRC cell lines. Furthermore, enhancing the expression of miR-339-5p inhibited CRC cell growth, migration and invasion in vitro and suppressed tumor growth in vivo. We then screened and identified a novel miR-339-5p target, phosphatases of regenerating liver-1 1 (PRL-1), and it was further confirmed by luciferase assay. Overexpression of miR-339-5p would also reduce the expression of PRL-1 mRNA and protein. The reduced PRL-1 expression was associated with low expression of phosphorylated-extracellular signal-regulated kinase1/2 (p-ERK1/2). Conversely, reduction of miR-339-5p by inhibitors in cells stimulated these phenotypes. In conclusion, our results demonstrate that miR-339-5p functions as a tumor suppressor and plays a role in inhibiting growth and metastasis of CRC cells through targeting PRL-1 and regulating p-ERK1/2 .These findings suggest that miR-339-5p may be useful as a new potential therapeutic target for CRC.
Bibliography:Competing Interests: The authers have declared that no competing interests exist.
Conceived and designed the experiments: CZ GL XL. Performed the experiments: CZ GL YL LY LZ FC FP. Analyzed the data: CZ GL XL. Contributed reagents/materials/analysis tools: CZ GL XL LW. Wrote the paper: CZ GL XL.
ISSN:1932-6203
1932-6203
DOI:10.1371/journal.pone.0063142